Pseudomonas aeruginosa biofilm is a potent inducer of phagocyte hyperinflammation by Ciszek-Lenda, Marta et al.
Vol.:(0123456789) 
Inflammation Research (2019) 68:397–413 
https://doi.org/10.1007/s00011-019-01227-x
ORIGINAL RESEARCH PAPER
Pseudomonas aeruginosa biofilm is a potent inducer of phagocyte 
hyperinflammation
Marta Ciszek‑Lenda1 · Magdalena Strus2 · Maria Walczewska1 · Grzegorz Majka1 · Agnieszka Machul‑Żwirbla2 · 
Diana Mikołajczyk2 · Sabina Górska3 · Andrzej Gamian3 · Benjamin Chain4 · Janusz Marcinkiewicz1 
Received: 7 March 2019 / Accepted: 10 March 2019 / Published online: 18 March 2019 
© The Author(s) 2019
Abstract
Objective Pseudomonas aeruginosa effectively facilitate resistance to phagocyte killing by biofilm formation. However, the 
cross talk between biofilm components and phagocytes is still unclear. We hypothesize that a biofilm provides a concentrated 
extracellular source of LPS, DNA and exopolysaccharides (EPS), which polarize neighbouring phagocytes into an adverse 
hyperinflammatory state of activation.
Methods We measured the release of a panel of mediators produced in vitro by murine neutrophils and macrophages exposed 
to various biofilm components of P. aeruginosa cultures.
Results We found that conditioned media from a high biofilm-producing strain of P. aeruginosa, PAR5, accumulated high 
concentrations of extracellular bacterial LPS, DNA and EPS by 72 h. These conditioned media induced phagocytes to release 
a hyperinflammatory pattern of mediators, with enhanced levels of TNF-α, IL-6, IL12p40,  PGE2 and NO. Moreover, the 
phagocytes also upregulated COX-2 and iNOS with no influence on the expression of arginase-1.
Conclusions Phagocytes exposed to biofilm microenvironment, called by us biofilm-associated neutrophils/macrophages 
(BANs/BAMs), display secretory properties similar to that of N1/M1-type phagocytes. These results suggest that in vivo 
high concentrations of LPS and DNA, trapped in biofilm by EPS, might convert infiltrating phagocytes into cells responsible 
for tissue injury without direct contact with bacteria and phagocytosis.
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Introduction
Pseudomonas aeruginosa is an opportunistic human 
pathogen that preferentially attacks immunocompromised 
patients and causes diverse chronic infections, such as 
severe nosocomial pneumonia and non-healing wounds 
[1–3]. Chronic lung infection with P. aeruginosa is a highly 
morbid complication that is particularly found in patients 
with cystic fibrosis (CF) [4]. P. aeruginosa has strong patho-
genicity and resistance to antibiotic therapy, largely due to 
its inherent biofilm-forming capacity [5]. Bacterial infec-
tions associated with biofilm formation are characterized 
by severe and progressive chronic inflammation, massive 
neutrophil infiltration but paradoxical resistance to immune 
attack [6, 7]. Two explanations for the increased resistance 
of biofilm-forming bacteria have been put forth: (1) bacte-
rial cells may be hidden in the biofilm matrix, such that their 
contact with antibacterial agents or immune cells is reduced; 
or (2) infiltrating phagocytes may be less effective in killing 
biofilm-hidden pathogens [8].
Mechanisms of tissue injury and chronic inflammation 
during chronic P. aeruginosa infections may reflect direct 
cytotoxic effects of P. aeruginosa toxins (e.g., rhamnolipids) 
and indirect effects of immunopathogenic mediators (e.g., 
NO, ROS, TNF-α) released from infiltrating phagocytes [9]. 
Biofilm formation is characterized by pronounced metabolic 
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changes of sessile bacteria and secretion of strain-specific 
extracellular polymeric substances, including exopolysac-
charides (EPSs), DNA, LPS and proteins [10–12]. These 
biofilm matrix components may, therefore, provide a con-
centrated extracellular source of PAMPS, which activate and 
polarize biofilm-infiltrating neutrophils and macrophages 
into more aggressive proinflammatory subtypes [13, 14]. 
Biofilm may, therefore, both protect bacteria from killing, 
yet activate hyperinflammation. It has been well documented 
that hyperinflammatory response, the effect of activation of 
neutrophils and macrophages with limited access to targets, 
does favor chronic inflammation without effective bacterial 
clearance [15–18]. Such reaction was also named as “frus-
trated phagocytosis” [19, 20].
We hypothesize that neutrophils and macrophages, upon 
contact with active biofilm matrix components such as found 
in a biofilm environment, polarize into biofilm-associated 
neutrophils (BANs) and biofilm-associated macrophages 
(BAMs). Based on previous studies [15, 21, 22], we sug-
gest that these phagocytes will be of hyperinflammatory 
phenotype, sometimes referred to as N1/M1 phenotypes. 
We explore this hypothesis by examining the inflammatory 
phenotype of macrophages and neutrophils exposed to P. 
aeruginosa extracellular products produced early (8 h) in 
culture, when biofilm production is just initiated, and P. aer-
uginosa extracellular products produced late (72 h), when 
massive biofilm production takes place.
Materials and methods
Characterization of P. aeruginosa strain PAR5
All experiments in this study were performed on mucoid 
P. aeruginosa strain coded as PAR5, which was selected 
from a larger collection out of 20 P. aeruginosa strains iso-
lated from patients with chronic non-healing diabetic foot 
infections. PAR5 has the ability to form the largest amount 
of biofilm mass compared to the same population of other 
strains from the collection [23, 24].
Growth conditions and measurement of biofilm formation 
by PAR5
The initial culture of PAR5 was propagated in 10 ml of tryp-
tic soy broth (TSB, Difco) at 37 °C for 24 h under aerobic 
conditions. After cultivation, bacteria were centrifuged for 
10 min at 500g and washed with 10 ml of phosphate buff-
ered saline (PBS, pH 7.4, Sigma-Aldrich). Bacterial count, 
confirmed by decimal dilutions, reached 1 × 108 CFU/ml.
Biofilm quantity (total mass of bacterial polysaccharides) 
was measured in sterile plastic 96-well plates with adherent 
surface (Greiner Bio-One) using Congo red dye according to 
a modified procedure described by Reuter et al. [25]. Briefly, 
20 µl of fresh culture of the bacterial suspensions, prepared 
as described above, was added to each well followed with 
180 µl of sterile TSB. Final concentration of the bacteria 
was 1 × 107CFU/ml. The plates were centrifuged for 10 min 
at 500g to sediment bacteria at the bottom of each well. 
Bacteria were then incubated for 72 h (37 °C, aerobic condi-
tions). At different time points of the culture (0, 8, 16, 24, 48 
and 72 h), the plates were centrifuged, the culture medium 
was gently removed from wells and, immediately, 200 µl of 
0.1% Congo red solution was added. The plates were left 
for 30 min at room temperature (RT) and washed twice with 
buffered saline to remove unbound dye. Absorbance was 
measured at λ = 492 nm wavelength using a spectrophotom-
eter (Awareness Technology Inc.). All measurements were 
performed in triplicates and mean values ± SD were given. 
The representative record of kinetics of bacteria growth and 
biofilm formation by PAR5 is shown in Fig. 1a, b. Moreover, 
SEM images of PAR5 cultures (0, 8, and 24 h) were pre-
pared (Fig. 1c). Bacterial morphology was examined under 
a scanning electron microscope (TESCAN). Coverslips were 
placed in a 12-well plate and treated with poly-l-lysine to 
enhance further bacterial cell adhesion. Glass slides were 
immersed in bacterial suspensions for 0, 8, and 24 h. Then, 
1 ml of fixing buffer (sodium cacodylate in 2.5% glutaral-
dehyde and 0.1 M sucrose) was added and the slides were 
incubated for 1.5 h at 37 °C. A dehydration procedure was 
applied in a gradient of methanol. Dried samples were sput-
tered with a 20-nm gold layer (Quorum, Q150R S) to facili-
tate SEM visualization [26].
PAR5 culture and preparation 
of bacterial‑conditioned media
1 ml of the bacterial suspension, prepared as described 
above, was added to sterile tubes, each containing 9 ml of 
fresh TSB broth, and cultured for either 8 h (planktonic stage 
of PAR5 cultures) or 72 h (mature biofilm stage of PAR5 
cultures). The bacteria were grown under aerobic conditions 
without shaking at 37 °C.
Fig. 1  The representative record of kinetics of biofilm formation by 
PAR5. a Density of PAR5 population at the indicated points of time 
is expressed in CFU of sessile cells per ml. The culture started with 
the bacterial suspension at a density of  107 CFU/ml. b Building of 
biofilm matrix. Congo red staining was used for measuring biofilm 
formation (EPS accumulation). Plot depicts mean values ± SD of 
absorbance (λ = 492  nm). The mean was calculated on the basis of 
three independent experiments (n = 3). a8-h PAR5 planktonic bacte-
ria cell attachment and the beginning of biofilm formation aa72 h—
mature biofilm. At these time points of the culture, the concentration 
of DNA, LPS and EPS in bacterial conditioned media is shown. c 
SEM of: 0-h PAR (free-floating planktonic bacteria); 8-h PAR5 (clus-
ter of planktonic bacteria, the beginning of biofilm formation); 24-h 
PAR5 (conglomerate cluster of bacteria—early biofilm)
◂
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PAR5‑8 h
After 8 h, the number of PAR5 cells present in the culture 
was estimated by making an appropriate decimal dilution 
of the bacteria in PBS and counting the bacterial colonies 
plated on McConkey agar (Oxoid) (Fig. 1a). The remaining 
volume of the PAR5 culture was centrifuged for 10 min at 
500g. Supernatant was transferred to a fresh tube, filtered 
with a 0.22-µm Millipore membrane, and stored at 4 °C until 
needed. This solution was labeled as BCM-8 h (planktonic 
bacterial-conditioned medium). The pellet of PAR5-8 h bac-
terial cells was washed with 10 ml PBS (pH 7.4) and stored 
at 4 °C.
PAR5‑72 h
The above steps were repeated after 72 h to collect PAR5-
72 h bacterial cells and BCM-72 h (mature biofilm-condi-
tioned medium) for further studies.
Killing P. aeruginosa PAR5 bacterial cells
PAR5 pellets originating from the 8- and 72-h cultures were 
treated thrice with high temperature (121 °C) at 0.3 bars in 
the ASVE-ELMI ESS-207 SMS steam sterilizer. The follow-
up culture was verified to be sterile.
Measurement of bacterial DNA in bacterial 
condition media
Extracellular bacterial DNA was isolated and purified from 
bacterial-conditioned media, according to the manufactur-
er’s protocol (Genomic Mini, A&A Biotechnology, Poland). 
Concentration of purified, specific-density DNA was deter-
mined with a spectrophotometer (DS-11; DeNovix Co.) at a 
wavelength of 260 nm.
Measurement of LPS concentration 
in bacterial‑conditioned media
Level of LPS in tested samples was estimated by use of 
QCL-1000 Chromogenic LAL test (Lonza) according to 
the manufacturer’s protocol. QCL-1000 is an assay for the 
detection of Gram-negative bacterial endotoxin.
DNA extraction
The bacterial cells from 72 h grown culture were harvested 
(8000 rpm, 10 °C, 15 min). The pellet was washed twice 
by PBS and again harvested. 0.25 ml of 10 mM Tris–HCl 
(pH 8) and 2.5 mg/ml of lysozyme were added and incu-
bated at 37 °C for 2 h. Then, 0.5 ml of lysis buffer (50 mM 
Tris, 100  mM EDTA, 1% SDS, pH 8) and 1  mg/ml of 
proteinase-K were added and incubated at 50 °C for 2 h in a 
water bath. The digestion with proteinase-K was followed by 
addition of 0.5 ml of phenol:chloroform (1:1). The samples 
were mixed gently for 3 min and harvested (14,000 rpm, 
4 °C, 15 min). The upper layer was transferred in fresh tube 
and extracted with chloroform:isoamyl alcohol (24:1) by the 
centrifugation at 14,000 rpm on 4 °C for 15 min. This step 
was repeated. The supernatant was precipitated with twice 
volume of ethanol and left till the precipitation was settled 
down. DNA was collected by centrifuging at 14,000 rpm, 
on 4 °C for 15 min and dried. The pellet was suspended in 
10 mM Tris–HCl (pH 8) and 1 mM EDTA (pH 8) buffer 
and incubated at 45 °C in a water bath for 3 h. The qual-
ity of DNA was checked using DS-11 spectrophotometer 
(DeNovix).
LPS isolation
LPS was isolated using hot phenol/water method and puri-
fied as described by Westphal et al. [27]. Quantity of LPS 
was measured after the sample lyophilisation.
EPS isolation
EPS was isolated as described previously [28]. The obtained 
material was purified by DNAse, RNAse and protease. Total 
saccharide concentration was measured by phenol sulfuric 
acid method according to Dubois’s method [29].
Fractionation of bacterial‑conditioned media
BCM-72 h in volumes of 2 ml was placed in Sartorius frac-
tionation columns (Vivacon 2) with molecular weight (MW) 
cut-off of 10 kDa and centrifuged for 30 min at 3500g at 
4 °C. Then, the lower fraction which was < 10 kDa MW 
was collected. Then, the columns were turn over and cen-
trifuged once more for 3 min at the same conditions to 
restore > 10 kDa MW fraction of BCM-72 h.
Mice
Inbred CBA mice (8–12 weeks of age, 18–22 g) were 
maintained at the Animal Breeding Unit of the Depart-
ment of Immunology of Jagiellonian University Medical 
College. All mice were held in standard caging conditions 
with water and standard diet ad libitum. This study was 
carried out in strict accordance with recommendations 
from the Guide for the Care and Use of Laboratory Ani-
mals of the Ministry of Science and Information of Poland. 
The protocol was approved by the I Local Committee on 
the Ethics of Animal Experiments of Jagiellonian Uni-
versity. All surgeries were performed under isoflurane 
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(Abbott Laboratories) anesthesia. Every effort was made 
to minimize animal suffering. Mice were used as donors 
for peritoneal exudate cells.
Cell isolation
Peritoneal mouse exudate cells (PEC) were induced by 
an intraperitoneal injection of 1.5 ml of 3% thioglycollate 
(Difco Laboratories). Mice were euthanized by overdosing 
with isoflurane vapors (Abbott Laboratories), followed by 
cervical dislocation. PEC were collected by washing out the 
peritoneal cavity with 5 ml of PBS (Lonza) containing 5 U 
heparin/ml (Polfa). Then, PEC were centrifuged, and red 
blood cells were lysed. Osmolarity was restored by addition 
of PBS. To obtain neutrophils, PEC were collected after 18 h 
or for macrophages 96 h after thioglycollate injections. For 
neutrophil collections, we have used 18-h thioglycollate-
induced peritoneal exudate cells. The cells were seeded 
to plastic plates and after 1 h, we collected non-adherent 
cells (neutrophils) for further experiments. For peritoneal 
macrophage isolation, we have used the method described 
previously [30]. At least three mice were used as donors of 
PEC for each experiment.
Cell culture and treatment
Neutrophils and macrophages were cultured in 24-well flat-
bottom cell culture plates at 5 × 105/well in IMDM medium 
(Lonza) supplemented with 5% fetal bovine serum (FBS; 
Lonza), 2 mM stable l-glutamine (Cytogen), and 50 mg/
ml gentamicin (KRKA) at 37 °C in an atmosphere of 5% 
 CO2. To determine the influence of the biofilm forms of 
P. aeruginosa on innate immune cell activity, neutrophils 
and macrophages were stimulated with heat-killed whole 
bacterial cells (PAR5-72 h 20:1 and 100:1 bacteria per 
cell) or with 72-h conditioned media from bacterial cul-
tures (BCM-72 h at 5–20% total volume), if not otherwise 
stated. The effect was compared with that of bacterial cells 
(PAR5-8 h) and 8-h conditioned media (BCM-8 h). As a 
reference stimulus for N1/M1 neutrophils/macrophages, we 
used 100 ng/ml LPS from Escherichia coli strain 0111:B4 
(LPS, Sigma-Aldrich). After 24 h of stimulation, culture 
supernatants were collected and frozen at − 80 °C until use. 
Cells were used in a western blot analysis. In some experi-
ments, neutrophils were cultured with BCM-72 h treated 
with inhibitors of DNA (BCM were incubated in the pres-
ence of 2.5 µl of 1500 Kunitz DNAse I, Qiagen; chloroquine, 
Sigma-Aldrich—2.5 µg/ml) or/and with the inhibitor of LPS 
(polymyxin B, Sigma-Aldrich, 100 µg/ml) or preincubated 
with EPS (30 µg/ml) for 1 h and then re-stimulated with LPS 
(100 ng/ml) or DNA (3 µg/ml).
Cell viability
Cell viability was monitored by mitochondrial-dependent 
reduction of MTT (Promega) to formazan and by means 
of LDH activity (lactate dehydrogenase) using LDH assay 
kit (Pierce) according to manufacturer’s instruction. The 
viability of phagocytes was controlled in all experimental 
systems to avoid cytotoxic effect of the tested agents. The 
lowest viability of neutrophils was approximately 78% (24 h 
after exposition to DNA), in other groups, the viability of 
neutrophils was ~ 80% and macrophages ~ 90%.
Cytokine determination
Cytokine levels in cell culture supernatants were measured 
by sandwich ELISA. Microtiter plates (Costar EIA/RIA 
plates, Corning Inc.) were coated with a cytokine-specific 
antibody. Expression levels of IL-6, IL-10, and IL-12p40 
were measured according to the manufacturer’s instructions 
(OptEIA Sets, BD Biosciences). TNF-α level was measured 
according to the manufacturer’s instructions (ELISA Ready-
Set-Go, eBioscience). In all cases, 10% FBS in PBS was 
used as a blocking solution. TMB substrate solution (Bio-
Legend) was used to develop a colorimetric reaction, which 
was stopped with 2 M sulfuric acid. Optical density was 
measured at 450 (570) nm using a microtiter plate reader 
(PowerWaveX, Bio-Tek Instruments).
Nitric oxide (NO) determination
NO levels in culture supernatants of peritoneal thioglycol-
late-induced cells (neutrophils, macrophages) were quanti-
fied by the accumulation of nitrite as a stable end product, 
according to a modified Griess method [31]. Cell culture 
supernatant (100 µl) was mixed with 14 mM 4,4′-diamino-
diphenylsulphone (Dapsone, Sigma-Aldrich) in 2 M HCl 
(50 µl) and 0.1% N-1-naphtylenediamine dihydrochloride 
(50 µl) in deionized water. Absorbance of the tested culture 
supernatants at 550 nm was compared with a sodium nitrate 
standard  (NaNO2) curve.
Prostaglandin  E2  (PGE2) immunoassay
PGE2 concentration in cell supernatants was determined by 
a  PGE2 high-sensitivity ELISA kit (Enzo Life Sciences), 
according to the manufacturer’s protocol.
Western blot analysis
24 h after in vitro stimulation of macrophages or neutrophils, 
expression levels of COX-2, iNOS, and arginase-1 (Arg-
1) proteins in cell cytosol were determined by western blot 
analysis. After incubation, cells were lysed in lysis buffer 
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(1% Triton X-100, 0.1% SDS in PBS) containing protease 
inhibitor cocktail (Sigma-Aldrich). Protein concentrations 
in lysates were determined using a bicinchoninic acid pro-
tein assay kit (Sigma-Aldrich). Samples containing equal 
amounts of total protein were mixed with gel loading buffer 
(0.125 M Tris, 4% SDS, 20% glycerol, 0.2 M dithiothreitol, 
0.02% bromophenol blue) in a 2:1 ratio (v/v) and boiled 
for 4 min. Samples of 20 µg of total protein per lane were 
separated on 10% SDS-polyacrylamide gels (Mighty Small 
II, Amersham Biosciences) using the Laemmli buffer sys-
tem. Proteins were transferred to nitrocellulose membranes 
(Bio-Rad). Non-specific binding sites were blocked over-
night at 4 °C with 3% non-fat dried milk. Membranes were 
incubated for 2 h at RT with rabbit polyclonal antibodies to 
COX-2 (cat. no. 160106, 1:1000, Cayman), Arg-1 (clone 
H-52, 1:600, Santa Cruz Biotechnology), or iNOS (ADI-
KAS-NO001, 1:2000, Enzo Life Sciences). Bands were 
detected with alkaline phosphatase-conjugated secondary 
goat antibody to the rabbit IgG whole molecule (A9919, 1 h 
at RT, 1:3000, Sigma-Aldrich) and developed with BCIP/
NBT alkaline phosphatase substrate (Sigma-Aldrich). Mem-
branes were re-probed with monoclonal mouse anti β-actin 
antibody (clone AC-15, 1 h at RT, 1:3000, Sigma-Aldrich). 
Pre-stained SDS-PAGE standards (low and high range; Bio-
Rad) were used for molecular weight (MW) determinations. 
Protein bands were scanned and analyzed with the Scion 
Image freeware (Scion Corp.). Data were normalized to the 
constitutive expression level of β-actin protein.
Data analysis
Statistical significance of differences between groups was 
analyzed using one-way ANOVA, followed, if significant, 
by a Dunnett’s test for post hoc comparison. In some experi-
ments, Student’s t test was used. Results are expressed as 
mean ± SEM values. A P value < 0.05 was considered statis-
tically significant. Analysis was performed using Graphpad 
Fig. 2  Cytokine production by neutrophils exposed to heat-killed bac-
teria cells (PAR5) or bacterial-conditioned media (BCM). Levels of 
TNF-α (a), IL-6 (b), IL-12p40 (c), and IL-10 (d) were analyzed by 
ELISA of supernatants collected from 24-h cultures of neutrophils 
(5 × 105/well). Neutrophils were activated with tested bacteria at 20:1 
and 100:1 ratios of PAR5:neutrophils or with bacterial-conditioned 
media (5, 10, 20% of total volume). Yellow bars: PAR5-8  h and 
BCM-8 h. Black bars: PAR5-72 h and BCM-72 h. Cytokine levels in 
non-stimulated cells were: TNF-α and IL-6 below the detection limit, 
for IL-10 and IL-12p40, < 0.075 and < 0.035  ng/ml, respectively. 
Data are mean ± SEM values of three independent experiments. Each 
group was run in triplicates. *p < 0.05, **p < 0.005  at 8  h vs. 72  h, 
Student’s t test. (Color figure online)
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Fig. 3  Cytokine production by macrophages exposed to heat-killed 
bacteria cells (PAR5) and bacterial-conditioned media (BCM). Levels 
of TNF-α (a), IL-6 (b), IL-12p40 (c), and IL-10 (d) were analyzed by 
ELISA of supernatants collected from 24-h cultures of macrophages 
(5 × 105/well). Macrophages were activated with tested bacteria 
used at 20:1 and 100:1 ratios of PAR5:macrophages or with bacte-
rial-conditioned media (5, 10, 20% of total volume). Orange bars: 
PAR5-8  h and BCM-8  h. Black bars: PAR5-72  h and BCM-72  h. 
Cytokine levels in non-stimulated cells were: TNF-α < 0.036  ng/ml, 
IL-6 below the detection limit, for IL-10 < 0.010 ng/ml and IL-12p40, 
< 0.180  ng/ml. Data are mean ± SEM values of three independent 
experiments. Each group was run in triplicates. *p < 0.05, **p < 0.005 
for 8 h vs. 72 h, Student’s t test. (Color figure online)
Fig. 4  Influence of indomethacin (Indo) on IL-6 secretion by neutro-
phils and macrophages stimulated with BCM-72  h. Neutrophils (a) 
and macrophages (b) at 5 × 105/well were stimulated with BCM-72 h 
(20%) in the presence or absence of Indo (10  µM). IL-6 level was 
analyzed in supernatants collected from 24-h cell cultures by ELISA. 
φ—non-stimulated cells, expressed IL-6 release below 0.1  ng/ml. 
Data are mean ± SEM values of three independent experiments. 
Groups were run in triplicates. ***p < 0.001 for BCM-72 h vs. BCM-
72 h + Indo, one-way ANOVA
404 M. Ciszek-Lenda et al.
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Prism v. 5.01 (GraphPad Software, Inc.). The exact statisti-
cal analysis is named in the relevant figure’s capitation.
Results
Cytokine production by cells exposed to P. 
aeruginosa PAR5
Pseudomonas aeruginosa switches from a planktonic to a 
biofilm-producing stage during prolonged culture in vitro. 
We exposed neutrophils and macrophages to killed bacteria 
cells (PAR5) or bacterial-conditioned media isolated from 
bacterial cultures after 8 h beginning of biofilm forma-
tion—planktonic stage of bacteria growth—see SEM images 
(Fig. 1) or 72 h (biofilm matrix formation—mature biofilm).
As shown in Fig. 2, neutrophils stimulated with PAR5-
72 h bacterial cells produced similar amounts of all tested 
cytokines (TNF-α, IL-6, IL-12p40, and IL-10) as those 
stimulated with PAR5-8 h bacteria. Macrophages, cultured 
under the same conditions, showed a trend towards higher 
production of TNF-α and IL-10, and a significantly higher 
production of IL-6 when stimulated with biofilm PAR5-72 h 
bacterial cells (Fig. 3). The ratio of bacteria to activated tar-
get cells (MOI—multiplicity of infection of 100:1 vs. 20:1 
bacteria per cell) had no substantial impact on the cytokine 
profile or total production.
On the other hand, comparison of bacterial supernatants, 
rather than cells, showed a different pattern. Neutrophils 
stimulated with BCM-72 h released significantly more IL-6 
and IL-12p40 than those stimulated with BCM-8 h (Fig. 2). 
The level of IL-6 in neutrophil cultures exposed to BCM-
72 h was more than tenfold higher than the level of IL-6 
stimulated with BCM-8 h (Fig. 2b). The stimulation of mac-
rophages with BCM-72 h showed a massive release of IL-6, 
and a trend towards increased IL-12p40 production (Fig. 3).
Importantly, the IL-6:IL-10 ratio reached 15:1 for mac-
rophages and 7:1 for neutrophils, suggesting a strong proin-
flammatory state of activation. An enhanced TNF-α:IL-10 
ratio in supernatants collected from the cells exposed to 
BCM-72 h (3:1 for neutrophils, 6:1 for macrophages) con-
firms the proinflammatory profile of these cells.
Moreover, the inhibition of prostaglandins production 
with indomethacin significantly reduced the production 
of IL-6, suggesting a positive proinflammatory feedback 
between these two mediators may operate (Fig. 4a, b).
iNOS, Arg‑1, and COX‑2 expression in cells exposed 
to P. aeruginosa PAR5
In parallel to determining cytokine secretion, we measured 
expression levels of iNOS, COX-2 and Arg-1. iNOS and 
COX-2 are proinflammatory enzymes responsible for pro-
ductions of NO and  PGE2, respectively, whereas Arg-1 is a 
key marker of immunoregulatory N2 neutrophils and M2 
macrophages [22, 32].
Stimulation of neutrophils and macrophages with 
PAR5-8 h and PAR5-72 bacteria caused a massive induc-
tion of iNOS and COX-2 proteins in these cells, together 
with significant secretion of nitrites (stable NO metabolites) 
and  PGE2 (> 1.5 ng/ml). There were no differences in Arg-1 
expression in cells stimulated with PAR5-8 h and PAR5-72 h 
(Figs. 5, 6).
Soluble products of P. aeruginosa (BCM) produced at 
early and late phases of culture differentially affected the 
expression levels of tested enzymes. BCM-8 h did not induce 
the expression of iNOS or COX-2 in inflammatory cells and 
the expression of Arg-1 was similar to that of control non-
stimulated cells (Figs. 5, 6). In contrast, BCM-72 h induced 
iNOS and COX-2 expression, similar to stimulation with 
LPS, the prototypical stimulus for proinflammatory N1/M1 
cells. However, neutrophils and macrophages stimulated 
with BCM-72 h produced substantial amounts of inflam-
matory  PGE2 (Figs. 5d, 6d) while the production of micro-
bicidal NO was negligible (Figs. 5b, 6b). All these results 
point to hyperinflammatory state of activation of the cells 
exposed to BCM-72 h.
Effect of LPS and DNA inhibitors on stimulatory 
properties of BCM‑72 h
While BCM-72 h showed a similar capacity to induce the 
production of proinflammatory mediators as whole bacte-
rial cells of PAR5, BCM-8 h showed only weak stimula-
tory properties. These observations suggest that BCM-8 h 
contains low subactive concentrations of active extracel-
lular bacterial biofilm products, consistent with previously 
reported growth rate of biofilm by P. aeruginosa [11, 23, 
33, 34]. As shown in Fig. 1b, a substantial amount of EPS 
produced by PAR5 was observed after 24 h of biofilm forma-
tion, followed by a plateau (48–72 h) and a breakdown of 
biofilm mass after 72 h of culture. In contrast, after 8 h, the 
EPS amount was negligible and cells could be considered as 
planktonic cells not hidden in a biofilm matrix. Moreover, 
BCM-8 h contained several times lower concentrations of 
Fig. 5  Expression of iNOS, COX-2, and Arg-1 proteins in neutro-
phils exposed to PAR5 or bacterial-conditioned media. Expression 
levels of iNOS (a), COX-2 (c), and Arg-1 (e) were measured by 
western blot analysis of cell lysates collected from 24-h cultures of 
neutrophils (5 × 105/well). Neutrophils were activated with tested bac-
teria at a ratio of 20:1 and 100:1 of PAR5:neutrophils, with bacterial-
conditioned media (the % of total volume) or with LPS (0.1 µg/ml) 
as a control. Densitometric analysis of bands from two experiments 
is shown. Data are normalized to constitutive expression levels of 
β-actin. In the same experiments, levels of  NO2 (b) and  PGE2 (d) in 
supernatants were measured. *p < 0.05, **p < 0.005 for 5% BCM-8 h 
vs. 5% BCN-72 h, one-way ANOVA
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LPS and DNA than BCM-72 h (Fig. 1b). This might explain 
weak stimulatory activity of BCM-8 h.
We, therefore, examined the contribution of different 
components of BCM-72 h to the activation of phagocytes 
in more detail. For this purpose, we focused on neutrophils, 
the major infiltrating cells in severe P. aeruginosa infections. 
First, we excluded the contribution of small molecules, such 
as QS molecules, in the biological activity of BCM-72 h. 
Fractions of BCM-72 h with MW below 10 kDa were not 
able to stimulate phagocytes for the production of cytokines. 
By contrast, the fractions with MW above 10 kDa showed 
the same stimulatory capacity as intact BCM-72 h (data not 
shown). Therefore, bacterial components of high MW, such 
as extracellular DNA, LPS and EPS, were the major candi-
dates to be held responsible for the proinflammatory proper-
ties of BCM-72 h.
Addition of DNase I and chloroquine (an endosomal 
acidification blocker and selective inhibitor of the DNA/
TLR9 pathway) [35], or polymyxin b (PMx, an inhibitor of 
LPS [36]) markedly blocked the ability of BCM to stimu-
late cytokine production by neutrophils (Fig. 7a–c). Impor-
tantly, the mixture of LPS and DNA inhibitors decreased 
both TNF-α and IL-6 production by more than 95%. This 
indicates that EPS did not contribute to BCM-72 h activity 
and suggests that EPS present in 20% BCM-72 h was at non-
stimulatory concentrations.
Stimulatory properties of purified LPS, DNA and EPS 
isolated from BCM‑72 h
To support the above observations, neutrophils were exposed 
to pure LPS, DNA and EPS isolated from BCM-72 h. First, 
we have estimated the lowest effective concentrations of the 
agents. All tested agents markedly stimulated IL-6 secretion 
from neutrophils at concentrations above 100 ng/ml for LPS, 
3 µg/ml for DNA and 30 µg/ml for EPS (data not shown).
Then, the activity of the agents, used at the above con-
centrations, was compared with the activity of E. coli 
LPS (100 ng/ml), referential stimulator of inflammatory 
mediators. As shown in Fig.  8, neutrophils exposed to 
DNA secreted significantly more tested cytokines than 
those stimulated with E. coli LPS. Importantly, the effect 
was observed at the concentration of DNA similar to that 
observed in BCM-72 h used in our experimental models 
(10% BCM-72 h).
By contrast, PAR5 LPS was weaker stimulator of neutro-
phil cytokine production than E. coli LPS. However, it favors 
the production of proinflammatory cytokines (TNF-α:IL-10 
ratio was 50:1 for PAR5 LPS and 10:1 for E.coli LPS).
EPS showed stimulatory properties similar to DNA but at 
the concentration much higher than that estimated in BCM 
72 h—20%. Importantly, joint effect of the agents on the 
production of proinflammatory cytokines (TNF-α, IL-6) 
was similar to that achieved by stimulation with DNA alone. 
Moreover, preincubation of neutrophils with EPS, the pri-
marily macromolecule of biofilm matrix, did not alter the 
neutrophil capacity to secrete inflammatory mediators after 
LPS and DNA stimulation (Fig. 8).
Discussion
Biofilm formation in the course of P. aeruginosa infections 
is associated with the development of chronic inflammation 
and pathogen persistence [5]. In this study, we demonstrate 
that biofilm is a rich source of concentrated extracellular 
phagocyte-activating bacterial components, including DNA, 
LPS and EPS. Importantly, our knowledge of bacteria–neu-
trophil interactions has evolved since discoveries of the 
different immunostimulatory properties of planktonic and 
biofilm forms of pathogens [8, 37]. Bacterial infections start 
with planktonic growth followed by a formation of biofilm. 
More importantly, interactions of bacteria with neutrophils 
at planktonic stage of infections usually result in pathogen 
killing, controlled production of inflammatory mediators, 
neutrophil apoptosis and the resolution of acute inflamma-
tion. On the contrary, the biofilm stage of bacterial infection 
favors necrosis of neutrophils and causes chronic inflamma-
tion [8, 21].
Chronic P. aeruginosa infection is the outcome of a com-
plex series of changes in P. aeruginosa phenotype. Infection 
with “wild-type” strains of P. aeruginosa is characterized by 
the proliferation of planktonic form of bacteria cells. Their 
long persistence is associated with complex mechanisms of 
adaptation and shift from planktonic to biofilm phenotypes. 
Moreover, biofilm-type pathogens undergo genetic, pheno-
typic and physiological diversification [38]. These biofilm-
forming strains colonize infected tissue and exist at various 
stages of biofilm development in numberless macrocolonies 
[39]. Such biofilm lifestyle cycle lasts 4–10 days and can be 
subdivided into following steps: attachment or aggregation 
of bacterial planktonic cells, formation of biofilm matrix, 
biofilm maturation, cell detachment and dispersion. Finally, 
such free-living biofilm cells, misleadingly termed as plank-
tonic cells, spread and colonize host tissues to form bio-
films at new sites [40]. Herein, in this study, all experiments 
were performed using the selected mucoid bacterial strain 
of P. aeruginosa showing a massive production of biofilm 
components.
The main objective of this study was to show that neutro-
phils and macrophages can be effectively stimulated by P. 
aeruginosa-derived biofilm extracellular substances without 
direct contact with bacterial cells, because the biofilm pro-
vides a very concentrated stable source of PAMPS which are 
otherwise present at very low concentrations in bacterial cul-
ture supernatant. We further hypothesize that the presence 
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Fig. 6  Expression of iNOS, COX-2 and Arg-1 proteins in mac-
rophages exposed to PAR5 or bacterial-conditioned media. Expres-
sion levels of iNOS (a), COX-2 (c), and Arg-1 (e) were measured by 
western blot analysis of cell lysates collected from 24-h cultures of 
macrophages (5 × 105/well). Macrophages were activated with tested 
bacteria at a ratio of 20:1 and 100:1 of PAR5:macrophages, with bac-
terial-conditioned media (the % of total volume) or with LPS (0.1 µg/
ml) as a control. Densitometric analysis of bands from two experi-
ments is shown. Data are normalized to constitutively expressed 
β-actin levels. In the same experiments, levels of  NO2 (b) and  PGE2 
(d) in supernatants were measured. ***p < 0.001 for 10% BCM-8 h 
vs.10% BCM-72  h, ###p < 0.001 for 20% BCM-8  h vs. 20% BCM-
72 h, one-way ANOVA
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of such stimulated cells (BANs, BAMs) in a hyperinflam-
matory state of activation may explain the detrimental role 
of neutrophils in chronic P. aeruginosa infection associated 
with the pathogenesis of CF [41, 42] and, as we have previ-
ously observed, in chronic rhinosinusitis [15].
We explored the role of the biofilm using, as a model, 
conditioned medium from a high biofilm producer strain 
of P. aeruginosa, and as responding innate immune cells 
murine macrophages and neutrophils. As we expected, 
72 h, but not 8-h cultures of P aeruginosa PAR5 were a 
rich source of biofilm components, including DNA, LPS and 
EPS. Importantly, the density of PAR5 in our experimental 
model of bacterial cultures  (107—5 × 109 CFU/ml) was simi-
lar to P. aeruginosa sputum densities demonstrated in cystic 
fibrosis patients [43]. The density of infiltrated neutrophils 
in CF sputum [44] is 10–20 times higher than the density 
of in vitro-stimulated leukocytes (5 × 105/ml). Therefore, 
one may expect even stronger hyperinflammatory response 
in vivo.
Conditioned medium from early cultures of PAR5, which 
contained small amounts of biofilm products, showed a weak 
stimulation of either neutrophils or macrophages. The lack 
of biofilm components at this time point is in agreement 
with the previously observed growth rate of P. aeruginosa 
biofilms and scant release of EPSs at this stage of biofilm 
development [23, 45].
However, when the PAR5 culture was extended to 72 h, 
biofilm production could easily be detected. In parallel, the 
conditioned medium (BCM-72 h) acquired strong stimula-
tory properties towards both neutrophils and macrophages. 
Specifically, the conditioned medium induced the release 
of TNF-α, IL-6, IL-12p40, NO, and  PGE2. Extremely high 
release of IL-6 was observed from targeted cell types, result-
ing in a high ratio of IL-6/IL-10, well-known pro- and anti-
inflammatory cytokines. To confirm a causal link between 
the increased concentrations of DNA and LPS associated 
with biofilm formation, and the immunostimulatory prop-
erties of the conditioned medium we removed DNA using 
DNAse enzyme, and blocked LPS activity using polymyxin 
Fig. 7  Effect of LPS and DNA inhibitors on stimulatory properties of 
BCM-72 h. Neutrophils at 5 × 105/well were cultured with 20% BCM-
72  h: (i) untreated, (ii) treated with DNA inhibitors (DNase and/or 
chloroquine), (iii) treated with inhibitor of LPS (PMx), (iv) treated 
with all tested inhibitors. TNF-α (a), IL-6 (b) and IL-10 (c) levels 
were analyzed by ELISA in supernatants collected from 24-h cell 
cultures. Data are mean ± SEM values of three independent experi-
ments. Each group was run in triplicates. *p < 0.05, **p < 0.005, 
***p < 0.001 between treated and untreated BCM-72  h, one-way 
ANOVA
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B. Both these components strongly contributed to the pro-
inflammatory activity of the conditioned medium, as their 
inhibition almost completely abolished the activity of BCM-
72 h. On the other hand, the incubation of neutrophils with 
pure DNA and LPS isolated from BCM-72 h showed that 
both agents, at concentrations close to those at 20% BCM-
72 h, markedly stimulated proinflammatory mediators.
Our results are in agreement with previous studies 
reported that components of biofilm matrix exert proin-
flammatory properties associated with the pathogenicity of 
biofilm-forming P. aeruginosa. These components primarily 
include QS molecules [9, 46], EPSs [10, 34], and finally, 
LPS and extracellular bacterial DNA, two major virulence 
and proinflammatory factors of P. aeruginosa biofilms [13, 
33, 47, 48]. We excluded the effect of QS molecules from 
our experiments because there was no BCM-72 h activity 
in the low MW fraction (< 10 kD). In addition, a combined 
neutralization of DNA and LPS completely blocked BCM-
72 h activity. Such blockade excluded the significant contri-
bution of other agents including EPS. Why EPS, the major 
component of P. aeruginosa biofilm, was not active? One 
possibility is that EPSs have a non-effective concentration in 
BCM-72 h. Indeed, we have shown that EPSs isolated from 
PAR5 BCM-72 h stimulate cytokine production by neutro-
phils at high concentrations (> 30 µg/ml) which were not 
achieved in the tested bacterial-conditioned media (< 20% 
BCM-72 h). Nevertheless, P. aeruginosa-derived EPS (e.g., 
alginate) may achieve very high concentrations in vivo at 
Fig. 8  Cytokine production by neutrophils exposed to agents isolated 
from BCM-72  h. Levels of TNF-α (a), IL-6 (b), IL-12p40 (c), and 
IL-10 (d) were analyzed by ELISA of supernatants collected from 
24-h cultures of neutrophils (5 × 105/well). Neutrophils were stimu-
lated with tested agents isolated from PAR5 BCM at concentrations: 
LPS—100  ng/ml, EPS—30  µg/ml and DNA—3  µg/ml. In two last 
groups, the cells were preincubated for 1  h with EPS and then re-
stimulated with LPS or DNA. After 24 h, supernatants were collected 
and the amounts of cytokines were estimated. Data are mean ± SEM 
values of three independent experiments. Each group was run in 
triplicates. As a control, LPS from E. coli was used (LPS, 100  ng/
ml). *p < 0.05, **p < 0.005, ***p < 0.001 vs. LPS E.coli, one-way 
ANOVA
410 M. Ciszek-Lenda et al.
1 3
chronic inflammation sites [49]. Therefore, in vivo, EPS not 
only protects bacteria hidden in a biofilm matrix against the 
immune attack, but also traps extracellular LPS and DNA 
to maintain their long-term effective immunostimulatory 
concentrations. Importantly, DNA and LPS, in contrast to 
EPS, can effectively activate inflammatory cells at very low 
concentrations (< 1 µg/ml) [48]. Indeed, in our experimental 
conditions, DNA and LPS, the major components of BCM-
72 h, independently stimulated the massive cytokine produc-
tion in neutrophils. These findings are consistent with previ-
ous observations that extracellular DNA, apart from its role 
in biofilm composition, is an extremely active component 
Fig. 9  Proposed model for cross talk between P. aeruginosa (PAR) 
and innate immunity (neutrophils and macrophages) at a site of acute 
and chronic inflammation. Acute infection and acute inflammation: at 
an early stage of infection planktonic form of P. aeruginosa induces 
an inflammatory response through TLRs at the site of bacteria entry. 
Activation of infiltrating neutrophils results in the production of 
inflammatory mediators and stimulation of phagocytosis, which kills 
planktonic bacterial cells. After eliminating pathogens, neutrophils 
die by apoptosis and are silently phagocytosed (neutrophil efferocy-
tosis) by macrophages. Finally, acute infection and inflammation are 
terminated. However, if pathogens are not killed they will attach to 
host cells, build a biofilm and chronic infection will develop. Chronic 
infection and chronic inflammation: bacteria that acquired biofilm-
type properties can survive as sessile cells in a few days long biofilm 
cycle (biofilm development stages: (1) irreversible attachment of 
bacteria to infected host cells or aggregation in body fluids, (2) bio-
film formation and maturation, (3) bacteria cell dispersion, coloniza-
tion of other sites, building one to three new biofilms). Formation of 
a biofilm matrix is accompanied by the local accumulation of EPSs, 
DNA, and LPS molecules reaching immunostimulatory concentra-
tions. In the course of biofilm maturation, extracellular LPS and 
DNA seem to be major stimulators of neutrophils (BANs) and mac-
rophages (BAMs), while EPS acts as a physical barrier and as a trap 
for other biofilm matrix components. The interaction between biofilm 
and BANs/BAMs might, therefore, favor hyperinflammation associ-
ated with tissue injury rather than effective killing of pathogens and 
resolution of acute inflammation. Such scenario is in agreement with 
clinical reports showing massive neutrophil infiltration in chronic P. 
aeruginosa infections with concomitant release of detrimental sub-
stances such as elastase, ROS, NO, prostaglandins and proinflamma-
tory cytokines
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of P. aeruginosa biofilms. Extracellular DNA triggers neu-
trophil activation through TLR9-dependent/-independent 
mechanisms, causes target cell death by necrosis and exac-
erbates chronic P. aeruginosa infections [12, 35, 48]. Moreo-
ver, it has been reported that DNA can initiate lung injury 
by stimulating neutrophil–endothelial cell interactions pre-
disposing to the increase in endothelial permeability [35].
Interestingly, the massive production of IL-6 and  PGE2 is 
in response to PAR5 stimulation. This observation confirms 
a role of the  PGE2/IL-6 axis in P. aeruginosa pathogenic-
ity. Indeed, IL-6 levels have been reported to be increased 
markedly in cystic fibrosis patients when the disease exac-
erbates [50–52]. Moreover, it has been demonstrated that 
IL-6 enhances mouse mortality in P. aeruginosa pulmonary 
infections [35, 52, 53]. The  PGE2/IL-6 axis promotes IL-23 
(IL-12p40), inhibits IL-12p70, and subsequently induces 
production of IL-17, the cytokine responsible for exacerba-
tion of chronic inflammatory processes [52, 54, 55].  PGE2 
also contributes to the suppression of innate immunity dur-
ing chronic mucosal bacterial infections [56–58].
Taken together, our finding partially explain why neu-
trophils infiltrating chronically infected tissue (e.g., CF 
airways) are not able to clear P. aeruginosa biofilm and 
contribute to tissue damage by releasing their danger-
ous cargo, as demonstrated in clinical studies [59]. This 
in vitro study showed that biofilm matrix components 
(LPS, DNA, EPS), without direct contact of bacteria and 
with phagocytes, stimulated release of proinflammatory 
mediators. Therefore, the interaction between biofilm and 
BAN/BAMs might favor chronic inflammation rather than 
effective killing of pathogens (“frustrated phagocytosis”) 
and resolution of inflammation (Fig. 9).
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